These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1134 related articles for article (PubMed ID: 34878337)
1. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity. Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337 [TBL] [Abstract][Full Text] [Related]
2. Create artilysins from a recombinant library to serve as bactericidal and antibiofilm agents targeting Pseudomonas aeruginosa. Zeng T; Liu S; Zou P; Yao X; Chen Q; Wei L; Wang Q; Zhang C; Zheng Y; Yu R Int J Biol Macromol; 2024 Jul; 273(Pt 2):132990. PubMed ID: 38857719 [TBL] [Abstract][Full Text] [Related]
3. Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302 [TBL] [Abstract][Full Text] [Related]
4. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens. Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094 [TBL] [Abstract][Full Text] [Related]
5. A Novel Antimicrobial Endolysin, LysPA26, against Guo M; Feng C; Ren J; Zhuang X; Zhang Y; Zhu Y; Dong K; He P; Guo X; Qin J Front Microbiol; 2017; 8():293. PubMed ID: 28289407 [TBL] [Abstract][Full Text] [Related]
6. Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens. Salpadoru T; Pinks KE; Lieberman JA; Cotton K; Wozniak KL; Gerasimchuk N; Patrauchan MA Microbiol Spectr; 2024 Jun; 12(6):e0423423. PubMed ID: 38651882 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients. Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293 [TBL] [Abstract][Full Text] [Related]
9. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415 [TBL] [Abstract][Full Text] [Related]
10. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. Lee MY; Ko KS; Song JH; Peck KR J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978 [TBL] [Abstract][Full Text] [Related]
11. Anti-biofilm and anti-inflammatory effects of Lycosin-II isolated from spiders against multi-drug resistant bacteria. Oh JH; Park J; Park Y Biochim Biophys Acta Biomembr; 2022 Feb; 1864(1):183769. PubMed ID: 34506798 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial peptide Reg4 ameliorates Wan X; Wang W; Zhu J; Xiao Y Microbiol Spectr; 2024 May; 12(5):e0390523. PubMed ID: 38501823 [No Abstract] [Full Text] [Related]
13. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009]. Hamouche E; Sarkis DK Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212 [TBL] [Abstract][Full Text] [Related]
14. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial peptide A20L: Zhou H; Du X; Wang Y; Kong J; Zhang X; Wang W; Sun Y; Zhou C; Zhou T; Ye J Microbiol Spectr; 2024 Aug; 12(8):e0397923. PubMed ID: 38980018 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains. de Lacerda Coriolano D; de Souza JB; Bueno EV; Medeiros SMFRDS; Cavalcanti IDL; Cavalcanti IMF Braz J Microbiol; 2021 Mar; 52(1):267-278. PubMed ID: 33231865 [TBL] [Abstract][Full Text] [Related]
17. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens. Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633 [TBL] [Abstract][Full Text] [Related]
18. Assessing the synergistic potential of bacteriophage endolysins and antimicrobial peptides for eradicating bacterial biofilms. Tyagi JL; Gupta P; Ghate MM; Kumar D; Poluri KM Arch Microbiol; 2024 May; 206(6):272. PubMed ID: 38772980 [TBL] [Abstract][Full Text] [Related]
19. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770 [TBL] [Abstract][Full Text] [Related]